Astellas and Universal Cells Ink $124M R&D Pact for Undisclosed Indication

  • Post author:
  • Post category:BioPharma

Universal Cells will get $9 million upfront and is eligible to regulatory milestones payments of up to $115 million, as well as royalties.
Source: BioSpace